Prostate Cancer with F-18 Sodium Fluoride
Sodium fluoride F-18 (NaF) is a positron-emitting radiotracer used in imaging patients with suspected bone metastases. NaF PET/MRI provides numerous advantages over the conventional technetium bone scans, most importantly higher sensitivity and specificity, greater spatial resolution, and significantly shorter uptake and scan times.
KeywordsSodium fluoride Bone scan Diffusion-weighted imaging F18 Blastic lesion Osseous metastasis Prostate cancer PET/MR
- Bastawrous S, Bhargava P, Behnia F, Djang DS, Haseley DR. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice. Radiographics. 2014;34(5):1295–316.Google Scholar
- Li Y, Schiepers C, Lake R, Dadparvar S, Berenji GR. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone. 2012;50(1):128–39.Google Scholar
- Mosavi F, Johansson S, Sandberg DT, Turesson I, Sörensen J, Ahlström H. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR Am J Roentgenol. 2012;199(5):1114–20.Google Scholar